Skip to Main content Skip to Navigation
Journal articles

The limitations of observation studies for decision making regarding drugs efficacy and safety

François Gueyffier 1 Michel Cucherat 2, 3
1 CIC CHU Lyon (inserm)
2 Evaluation et modélisation des effets thérapeutiques
Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]
3 SHUPT Lyon - Service Hospitalo-Universitaire de Pharmacologie et Toxicologie - Lyon
Abstract : After looking at some case studies, we will remind in this paper how observational studies regarding drug exposure or delivery are prone to various biases and structural limitations. These biases lead us to be extremely cautious regarding the implementation of results from such studies in clinical practice, and to question the reliability of such studies to determine the position of a given treatment into the therapeutic strategy. We will conclude on the respective place of randomized controlled trials (RCTs) and observational approaches, which are obviously complementary, but not interchangeable.
Keywords : Level of evidence Biases Net benefit Observational studies Pharmacoepidemiology
Document type :
Journal articles
Complete list of metadata
https://hal-hcl.archives-ouvertes.fr/hal-02112665
Contributor : Michel Cucherat <>
Submitted on : Friday, April 26, 2019 - 6:12:36 PM
Last modification on : Tuesday, July 20, 2021 - 5:20:07 PM

Links full text

openaccess

Identifiers

Collections

HCL | CNRS | BIOENVIS | UNIV-LYON1 | INRIA | INSERM | UDL

Citation

François Gueyffier, Michel Cucherat. The limitations of observation studies for decision making regarding drugs efficacy and safety. Alternative and Complementary Therapies, Mary Ann Liebert, 2019, 74 (2), pp.181-185. ⟨10.1016/j.therap.2018.11.001⟩. ⟨hal-02112665⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

153